. "The Current Status and Future Outlook for Genomic Technologies--Mostafa Ronaghi and Jeffrey Fisher." Frontiers of Engineering: Reports on Leading-Edge Engineering from the 2010 Symposium. Washington, DC: The National Academies Press, 2010.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Frontiers of Engineering: Reports on Leading-Edge Engineering from the 2010 Symposium
Genomics has emerged as an important tool for studying biological systems. Significant cost reductions in genomic sequencing have accelerated the adaptation of this technology for applications in a variety of market segments (e.g., research, forensics, consumer products, agriculture, and diagnostics). The most important factor in reducing cost is increasing throughput per day. We predict that the cost of sequencing an entire genome will drop to a few hundred dollars in the next few years as throughput rises with increasing density, longer read length, and shorter cycle time.
In a year or so, the cost of genome sequencing will be less than the cost of single-gene testing, which by itself has already brought significant cost savings to health care. We also predict that genome sequencing will soon become a standard part of medical practice and that in the next 15 years everybody in the Western world will be genome-sequenced.
Balmain, A., J. Gray, and B. Ponder. 2003. The genetics and genomics of cancer. Nature Genetics 33(Suppl): 238–244.
Bentley, D.R. 2006. Whole-genome re-sequencing. Current Opinion in Genetics and Development 16(6): 545–552.
Bentley, D.R., et al. 2008. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456(7218): 53–59.
Bibikova, M., D. Talantov, E. Chudin, J. M. Yeakley, J. Chen, D. Doucet, E. Wickham, D. Atkins, D. Barker, M. Chee, Y. Wang, and J.-B. Fan. 2004. Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays. American Journal of Pathology 165(5): 1799–1807.
Gill, S.R., M. Pop, R.T. DeBoy, P.B. Eckburg, P.J. Turnbaugh, B.S. Samuel, J.I. Gordon, D.A. Relman, C.M. Fraser-Liggett, and K. E. Nelson. 2006. Metagenomic analysis of the human distal gut microbiome. Science 312(5778): 1355–1359.
Jones, P.A., and S.B. Baylin. 2002. The fundamental role of epigenetic events in cancer. Nature Reviews. Genetics 3(6): 415–428.
Kurimoto, K., and M. Saitou. 2010. Single-cell cDNA microarray profiling of complex biological processes of differentiation. Current Opinion in Genetics and Development 20(5): 470–477.
Lengauer, C., K.W. Kinzler, and B. Vogelstein. 1998. Genetic instabilities in human cancers. Nature 396(6712): 643–649.
Lennon, N. 2010. Optimization of Sample Preparation for Next-Generation Sequencing. Presented at the Evolution of Next-Generation Sequencing Conference, September 27–29, 2010, Providence, Rhode Island.
Lewis, F., N.J. Maughan, V. Smith, K. Hillan, and P. Quirke. 2001. Unlocking the archive–gene expression in paraffin-embedded tissue. Journal of Pathology 195(1): 66–71.
Loeb, L.A. 1991. Mutator phenotype may be required for multistage carcinogenesis. Cancer Research 51(12): 3075–3079.
Loeb, L.A. 2001. A mutator phenotype in cancer. Cancer Research 61(8): 3230–3239.